Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development
The latest news from Hims & Hers, Atropos Health, Signal 1, NewYork-Presbyterian, Sharecare, Novo Nordisk, H1, Strida, Hackensack Meridian Health and ModMed.
In the week of August 3-7, Hers launched a new AI-native app offering both doctor-led and AI-driven care, with weight loss members gaining first access. The platform integrates a smart scale that tracks weight and GLP-1 progress, syncing data with healthcare providers for round-the-clock support. Hims & Hers, the company behind Hers, developed the AI tool to address the gaps in care after hours, providing personalized assistance linked to clinical protocols developed with weight-loss specialists.
By embedding intelligence throughout the care experience, Hers aims to offer expert-led, personalized support tailored to individual needs.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
